Plain-English translation of NCT06313749 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new surgical procedure called MIMS® (minimally invasive micro sclerostomy) for people with open-angle glaucoma whose eye pressure remains too high despite using multiple eye drop medications. The MIMS® procedure is a less-invasive surgery designed to help drain fluid from the eye and lower pressure. Researchers want to see if this new treatment works as well as or better than the traditional glaucoma surgery called trabeculectomy.
Many people with glaucoma cannot control their eye pressure even when using multiple eye drop medications, which puts them at risk of vision loss. This trial exists to test whether the MIMS® procedure offers a gentler surgical option that works well for these patients who need surgery but want a less invasive approach.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive the MIMS® surgical procedure at one of several study sites. After surgery, you will return for follow-up eye exams over a 12-month period so doctors can monitor your eye pressure, vision, and overall eye health to see how well the new surgery works. The study team will compare your results to historical data from people who had the traditional trabeculectomy surgery.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States